hVIVO plc (LON:HVO – Get Free Report) was up 10.3% during mid-day trading on Monday . The stock traded as high as GBX 21.50 ($0.27) and last traded at GBX 21.31 ($0.27). Approximately 3,194,943 shares changed hands during mid-day trading, an increase of 18% from the average daily volume of 2,705,167 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Stock Performance
The firm has a fifty day simple moving average of GBX 20.36 and a 200-day simple moving average of GBX 25.73. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The company has a market cap of £145.01 million, a PE ratio of 710.47 and a beta of 0.97.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Further Reading
- Five stocks we like better than hVIVO
- What Do S&P 500 Stocks Tell Investors About the Market?
- 5 Space Stocks to Watch as the Industry Reaches New Heights
- Best Stocks Under $5.00
- MP Materials: Rare Earth Elements Powering the EV Boom
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
